USA Follow-on Biologics Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Follow-on Biologics market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Follow-on Biologics market. Detailed analysis of key players, along with key growth strategies adopted by Follow-on Biologics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Dr Reddy's Laboratories

    • Teva Pahrmaceutical

    • Amgen

    • Biocon

    • Mylan

    • Samsung Biologics

    • Celltrion

    • Sandoz

    • Pfizer

    • Stada Arzneimittel AG

    By Type:

    • Recombinant Non-glycosylated Proteins

    • Recombinant Glycosylated Proteins

    • Recombinant Peptides

    By End-User:

    • Oncology

    • Blood Disorders

    • Chronic Diseases

    • Autoimmune Diseases

    • Growth Hormone Deficiency

    • Infectious Diseases

    • Other Diseases

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Follow-on Biologics Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Follow-on Biologics Market Size and Growth Rate of Recombinant Non-glycosylated Proteins from 2016 to 2027

      • 1.3.2 USA Follow-on Biologics Market Size and Growth Rate of Recombinant Glycosylated Proteins from 2016 to 2027

      • 1.3.3 USA Follow-on Biologics Market Size and Growth Rate of Recombinant Peptides from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Follow-on Biologics Market Size and Growth Rate of Oncology from 2016 to 2027

      • 1.4.2 USA Follow-on Biologics Market Size and Growth Rate of Blood Disorders from 2016 to 2027

      • 1.4.3 USA Follow-on Biologics Market Size and Growth Rate of Chronic Diseases from 2016 to 2027

      • 1.4.4 USA Follow-on Biologics Market Size and Growth Rate of Autoimmune Diseases from 2016 to 2027

      • 1.4.5 USA Follow-on Biologics Market Size and Growth Rate of Growth Hormone Deficiency from 2016 to 2027

      • 1.4.6 USA Follow-on Biologics Market Size and Growth Rate of Infectious Diseases from 2016 to 2027

      • 1.4.7 USA Follow-on Biologics Market Size and Growth Rate of Other Diseases from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Follow-on Biologics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Follow-on Biologics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Follow-on Biologics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Follow-on Biologics Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Follow-on Biologics Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Follow-on Biologics by Major Types

      • 3.4.1 Market Size and Growth Rate of Recombinant Non-glycosylated Proteins

      • 3.4.2 Market Size and Growth Rate of Recombinant Glycosylated Proteins

      • 3.4.3 Market Size and Growth Rate of Recombinant Peptides

    4 Segmentation of Follow-on Biologics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Follow-on Biologics by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Follow-on Biologics in Oncology

      • 4.4.2 Market Size and Growth Rate of Follow-on Biologics in Blood Disorders

      • 4.4.3 Market Size and Growth Rate of Follow-on Biologics in Chronic Diseases

      • 4.4.4 Market Size and Growth Rate of Follow-on Biologics in Autoimmune Diseases

      • 4.4.5 Market Size and Growth Rate of Follow-on Biologics in Growth Hormone Deficiency

      • 4.4.6 Market Size and Growth Rate of Follow-on Biologics in Infectious Diseases

      • 4.4.7 Market Size and Growth Rate of Follow-on Biologics in Other Diseases

    5 Market Analysis by Regions

    • 5.1 USA Follow-on Biologics Production Analysis by Regions

    • 5.2 USA Follow-on Biologics Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Follow-on Biologics Landscape Analysis

    • 6.1 West USA Follow-on Biologics Landscape Analysis by Major Types

    • 6.2 West USA Follow-on Biologics Landscape Analysis by Major End-Users

    7 South USA Follow-on Biologics Landscape Analysis

    • 7.1 South USA Follow-on Biologics Landscape Analysis by Major Types

    • 7.2 South USA Follow-on Biologics Landscape Analysis by Major End-Users

    8 Middle West USA Follow-on Biologics Landscape Analysis

    • 8.1 Middle West USA Follow-on Biologics Landscape Analysis by Major Types

    • 8.2 Middle West USA Follow-on Biologics Landscape Analysis by Major End-Users

    9 Northeast USA Follow-on Biologics Landscape Analysis

    • 9.1 Northeast USA Follow-on Biologics Landscape Analysis by Major Types

    • 9.2 Northeast USA Follow-on Biologics Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Dr Reddy's Laboratories

        • 10.1.1 Dr Reddy's Laboratories Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Teva Pahrmaceutical

        • 10.2.1 Teva Pahrmaceutical Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Amgen

        • 10.3.1 Amgen Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Biocon

        • 10.4.1 Biocon Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Mylan

        • 10.5.1 Mylan Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Samsung Biologics

        • 10.6.1 Samsung Biologics Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Celltrion

        • 10.7.1 Celltrion Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Sandoz

        • 10.8.1 Sandoz Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Pfizer

        • 10.9.1 Pfizer Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Stada Arzneimittel AG

        • 10.10.1 Stada Arzneimittel AG Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Follow-on Biologics Market Size and Growth Rate of Recombinant Non-glycosylated Proteins from 2016 to 2027

    • Figure USA Follow-on Biologics Market Size and Growth Rate of Recombinant Glycosylated Proteins from 2016 to 2027

    • Figure USA Follow-on Biologics Market Size and Growth Rate of Recombinant Peptides from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Follow-on Biologics Market Size and Growth Rate of Oncology from 2016 to 2027

    • Figure USA Follow-on Biologics Market Size and Growth Rate of Blood Disorders from 2016 to 2027

    • Figure USA Follow-on Biologics Market Size and Growth Rate of Chronic Diseases from 2016 to 2027

    • Figure USA Follow-on Biologics Market Size and Growth Rate of Autoimmune Diseases from 2016 to 2027

    • Figure USA Follow-on Biologics Market Size and Growth Rate of Growth Hormone Deficiency from 2016 to 2027

    • Figure USA Follow-on Biologics Market Size and Growth Rate of Infectious Diseases from 2016 to 2027

    • Figure USA Follow-on Biologics Market Size and Growth Rate of Other Diseases from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Follow-on Biologics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Follow-on Biologics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Follow-on Biologics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Follow-on Biologics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Follow-on Biologics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Follow-on Biologics

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Follow-on Biologics by Different Types from 2016 to 2027

    • Table Consumption Share of Follow-on Biologics by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Recombinant Non-glycosylated Proteins

    • Figure Market Size and Growth Rate of Recombinant Glycosylated Proteins

    • Figure Market Size and Growth Rate of Recombinant Peptides

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Follow-on Biologics by Different End-Users from 2016 to 2027

    • Table Consumption Share of Follow-on Biologics by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Oncology

    • Figure Market Size and Growth Rate of Blood Disorders

    • Figure Market Size and Growth Rate of Chronic Diseases

    • Figure Market Size and Growth Rate of Autoimmune Diseases

    • Figure Market Size and Growth Rate of Growth Hormone Deficiency

    • Figure Market Size and Growth Rate of Infectious Diseases

    • Figure Market Size and Growth Rate of Other Diseases

    • Table USA Follow-on Biologics Production by Regions

    • Table USA Follow-on Biologics Production Share by Regions

    • Figure USA Follow-on Biologics Production Share by Regions in 2016

    • Figure USA Follow-on Biologics Production Share by Regions in 2021

    • Figure USA Follow-on Biologics Production Share by Regions in 2027

    • Table USA Follow-on Biologics Consumption by Regions

    • Table USA Follow-on Biologics Consumption Share by Regions

    • Figure USA Follow-on Biologics Consumption Share by Regions in 2016

    • Figure USA Follow-on Biologics Consumption Share by Regions in 2021

    • Figure USA Follow-on Biologics Consumption Share by Regions in 2027

    • Table West USA Follow-on Biologics Consumption by Types from 2016 to 2027

    • Table West USA Follow-on Biologics Consumption Share by Types from 2016 to 2027

    • Figure West USA Follow-on Biologics Consumption Share by Types in 2016

    • Figure West USA Follow-on Biologics Consumption Share by Types in 2021

    • Figure West USA Follow-on Biologics Consumption Share by Types in 2027

    • Table West USA Follow-on Biologics Consumption by End-Users from 2016 to 2027

    • Table West USA Follow-on Biologics Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Follow-on Biologics Consumption Share by End-Users in 2016

    • Figure West USA Follow-on Biologics Consumption Share by End-Users in 2021

    • Figure West USA Follow-on Biologics Consumption Share by End-Users in 2027

    • Table South USA Follow-on Biologics Consumption by Types from 2016 to 2027

    • Table South USA Follow-on Biologics Consumption Share by Types from 2016 to 2027

    • Figure South USA Follow-on Biologics Consumption Share by Types in 2016

    • Figure South USA Follow-on Biologics Consumption Share by Types in 2021

    • Figure South USA Follow-on Biologics Consumption Share by Types in 2027

    • Table South USA Follow-on Biologics Consumption by End-Users from 2016 to 2027

    • Table South USA Follow-on Biologics Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Follow-on Biologics Consumption Share by End-Users in 2016

    • Figure South USA Follow-on Biologics Consumption Share by End-Users in 2021

    • Figure South USA Follow-on Biologics Consumption Share by End-Users in 2027

    • Table Middle West USA Follow-on Biologics Consumption by Types from 2016 to 2027

    • Table Middle West USA Follow-on Biologics Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Follow-on Biologics Consumption Share by Types in 2016

    • Figure Middle West USA Follow-on Biologics Consumption Share by Types in 2021

    • Figure Middle West USA Follow-on Biologics Consumption Share by Types in 2027

    • Table Middle West USA Follow-on Biologics Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Follow-on Biologics Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Follow-on Biologics Consumption Share by End-Users in 2016

    • Figure Middle West USA Follow-on Biologics Consumption Share by End-Users in 2021

    • Figure Middle West USA Follow-on Biologics Consumption Share by End-Users in 2027

    • Table Northeast USA Follow-on Biologics Consumption by Types from 2016 to 2027

    • Table Northeast USA Follow-on Biologics Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Follow-on Biologics Consumption Share by Types in 2016

    • Figure Northeast USA Follow-on Biologics Consumption Share by Types in 2021

    • Figure Northeast USA Follow-on Biologics Consumption Share by Types in 2027

    • Table Northeast USA Follow-on Biologics Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Follow-on Biologics Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Follow-on Biologics Consumption Share by End-Users in 2016

    • Figure Northeast USA Follow-on Biologics Consumption Share by End-Users in 2021

    • Figure Northeast USA Follow-on Biologics Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Dr Reddy's Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dr Reddy's Laboratories

    • Figure Sales and Growth Rate Analysis of Dr Reddy's Laboratories

    • Figure Revenue and Market Share Analysis of Dr Reddy's Laboratories

    • Table Product and Service Introduction of Dr Reddy's Laboratories

    • Table Company Profile and Development Status of Teva Pahrmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pahrmaceutical

    • Figure Sales and Growth Rate Analysis of Teva Pahrmaceutical

    • Figure Revenue and Market Share Analysis of Teva Pahrmaceutical

    • Table Product and Service Introduction of Teva Pahrmaceutical

    • Table Company Profile and Development Status of Amgen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen

    • Figure Sales and Growth Rate Analysis of Amgen

    • Figure Revenue and Market Share Analysis of Amgen

    • Table Product and Service Introduction of Amgen

    • Table Company Profile and Development Status of Biocon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon

    • Figure Sales and Growth Rate Analysis of Biocon

    • Figure Revenue and Market Share Analysis of Biocon

    • Table Product and Service Introduction of Biocon

    • Table Company Profile and Development Status of Mylan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan

    • Figure Sales and Growth Rate Analysis of Mylan

    • Figure Revenue and Market Share Analysis of Mylan

    • Table Product and Service Introduction of Mylan

    • Table Company Profile and Development Status of Samsung Biologics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Samsung Biologics

    • Figure Sales and Growth Rate Analysis of Samsung Biologics

    • Figure Revenue and Market Share Analysis of Samsung Biologics

    • Table Product and Service Introduction of Samsung Biologics

    • Table Company Profile and Development Status of Celltrion

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celltrion

    • Figure Sales and Growth Rate Analysis of Celltrion

    • Figure Revenue and Market Share Analysis of Celltrion

    • Table Product and Service Introduction of Celltrion

    • Table Company Profile and Development Status of Sandoz

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sandoz

    • Figure Sales and Growth Rate Analysis of Sandoz

    • Figure Revenue and Market Share Analysis of Sandoz

    • Table Product and Service Introduction of Sandoz

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Stada Arzneimittel AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Stada Arzneimittel AG

    • Figure Sales and Growth Rate Analysis of Stada Arzneimittel AG

    • Figure Revenue and Market Share Analysis of Stada Arzneimittel AG

    • Table Product and Service Introduction of Stada Arzneimittel AG


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.